COGNANO Inc. (Headquartered in Kyoto, Japan) is pleased to announce its participation as a new member of OpenFold, a non-profit consortium dedicated to advancing AI-powered tools for structural biology and drug discovery.
At COGNANO, we uniquely maintain and manage in-house populations of alpacas and sharks, enabling the collection of a rare and large-scale dataset of VHH antibodies. Leveraging this valuable resource, we combine statistical modeling techniques with large language models (LLMs) to efficiently and accurately identify novel antigens — a key step in next-generation biologics discovery.
By joining OpenFold, COGNANO aims to contribute its unique biological assets and AI-driven discovery expertise to the global research community. Together with leading pharmaceutical companies, biotech innovators, and academic institutions, we will help accelerate the development of advanced protein structure prediction technologies and unlock new possibilities in therapeutic design.
COGNANO remains committed to transforming the future of drug discovery through the fusion of biodiversity and state-of-the-art AI.
About OpenFold
OpenFold is a non-profit AI research consortium focused on open-source development of high-performance protein structure prediction tools. It brings together stakeholders from academia and industry to drive innovation in structural biology and drug discovery.
Related Links: